NBIX
Neurocrine Biosciences Inc
145.50$
+0.9%
vs. previous close
Closing price · As of: Oct 6, 2026
Statements
Income Statement
All figures per share in USD.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 4.93 | 5.04 | 4.97 | 5.68 | 5.96 | 6.10 | 5.59 | 6.81 | 7.76 | 7.86 | 7.88 | 9.20 | 32.38 | |
| 0.11 | 0.08 | 0.07 | 0.09 | 0.08 | 0.09 | 0.09 | 0.11 | 0.14 | 0.17 | 0.13 | 0.22 | 0.66 | |
| 4.82 | 4.95 | 4.90 | 5.59 | 5.89 | 6.01 | 5.50 | 6.70 | 7.62 | 7.69 | 7.74 | 8.98 | 31.72 | |
| 1.41 | 1.34 | 1.54 | 1.84 | 1.87 | 1.80 | 2.57 | 2.42 | 2.44 | 2.52 | 2.86 | 3.14 | 10.86 | |
| 2.02 | 2.14 | 2.35 | 2.33 | 2.25 | 2.80 | 2.70 | 2.83 | 2.84 | 2.94 | 3.08 | 4.22 | 12.97 | |
| 3.43 | 3.48 | 3.94 | 4.19 | 4.13 | 4.63 | 5.27 | 5.25 | 5.29 | 5.63 | 5.94 | 7.51 | 24.15 | |
| 1.40 | 1.47 | 0.96 | 1.40 | 1.76 | 1.38 | 0.23 | 1.44 | 2.33 | 2.06 | 1.80 | 1.47 | 7.57 | |
| 0.01 | 0.01 | 0.01 | 0.48 | – | – | – | 0.00 | – | – | – | 0.03 | – | |
| 1.14 | 1.94 | 0.33 | 0.95 | 1.82 | 1.58 | 0.14 | 1.58 | 2.85 | 2.34 | 2.39 | 1.56 | 9.02 | |
| 0.32 | 0.49 | -0.09 | 0.32 | 0.58 | 0.58 | 0.07 | 0.51 | 0.80 | 0.84 | 0.47 | 0.17 | 2.25 | |
| 0.82 | 1.44 | 0.42 | 0.63 | 1.24 | 1.00 | 0.08 | 1.06 | 2.04 | 1.50 | 1.91 | 1.39 | 6.77 | |
| 1.21 | 2.00 | 1.08 | 1.49 | 1.83 | 1.77 | 0.31 | 1.65 | 2.92 | 2.30 | 1.87 | 1.82 | 8.81 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 6, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.